{
    "Trade/Device Name(s)": [
        "D3 FastPoint L-DFA Influenza A/Influenza B Virus Identification Kit",
        "D\u00b2 FastPoint L-DFA Influenza A/Influenza B Virus Identification Kit"
    ],
    "Submitter Information": "Diagnostic Hybrids, Inc.",
    "510(k) Number": "K092882",
    "Predicate Device Reference 510(k) Number(s)": [
        "K061101",
        "K081928"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "GNW",
        "GNX"
    ],
    "Summary Letter Date": "September 14, 2009",
    "Summary Letter Received Date": "September 18, 2009",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.3330"
    ],
    "Regulation Name(s)": [
        "Influenza virus serological reagents"
    ],
    "Analyte Class(es)": [
        "virology",
        "microbiology"
    ],
    "Analyte(s)": [
        "Influenza A virus",
        "Influenza B virus"
    ],
    "Specimen Type(s)": [
        "Nasal swab",
        "Nasopharyngeal swab",
        "Aspirate",
        "Wash"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Fluorescence microscope"
    ],
    "Method(s)/Technology(ies)": [
        "Direct fluorescent antibody (DFA)",
        "Immunofluorescence"
    ],
    "Methodologies": [
        "Direct immunofluorescence",
        "Monoclonal antibody staining"
    ],
    "Submission Type(s)": [
        "Kit",
        "Reagent",
        "Antigen control slides"
    ],
    "Document Summary": "FDA 510(k) summary for D3 FastPoint L-DFA Influenza A/Influenza B Virus Identification Kit, a direct immunofluorescence assay for detection of influenza A and B in respiratory specimens.",
    "Indications for Use Summary": "Qualitative identification of influenza A and influenza B viruses in nasal and nasopharyngeal swabs and aspirates/washes from patients with signs and symptoms of respiratory infection by direct immunofluorescence.",
    "fda_folder": "Microbiology"
}